General Manager Cheng Zhenghui of APT Medical Inc. (688617.SH) plans to reduce his shareholding by no more than 1.5%.
APT Medical Inc. (688617.SH) announced that today the company received a "Notification Letter Regarding the Share Reduction Plan" from Mr. Cheng Zhenghui, a shareholder holding more than 5% of the company's shares, Vice Chairman, and General Manager. The reducing shareholder intends to reduce its holdings of the company's shares through block trades, totaling no more than 2,122,900 shares, i.e., no more than 1.5% of the company's total share capital.
APT Medical Inc. (688617.SH) announced that today the company received a "Notification Letter Regarding the Share Reduction Plan" issued by Mr. Cheng Zhenghui, a shareholder holding more than 5% of the company's shares, Vice Chairman, and General Manager. The reducing shareholder intends to reduce its holdings of the company's shares through block trades, totaling no more than 2,122,900 shares, i.e., no more than 1.5% of the company's total share capital.
Related Articles
Primarius Technologies (688206.SH) shareholders plan to reduce their holdings by no more than 2% in total.
EFORT Intelligent Equipment (688165.SH) shareholder Xinwei Jishi and its concerted parties plan to reduce their shareholding by no more than 3%.
Shanghai Shen Lian Biomedical Corporation (688098.SH): Phase II clinical trial of UB-221 for the treatment of chronic spontaneous urticaria meets primary endpoint
Primarius Technologies (688206.SH) shareholders plan to reduce their holdings by no more than 2% in total.
EFORT Intelligent Equipment (688165.SH) shareholder Xinwei Jishi and its concerted parties plan to reduce their shareholding by no more than 3%.
Shanghai Shen Lian Biomedical Corporation (688098.SH): Phase II clinical trial of UB-221 for the treatment of chronic spontaneous urticaria meets primary endpoint
RECOMMEND
